Premature termination of transcription influences ribosomal RNA output and RNA polymerase I drug sensitivity, revealing a mechanism of resistance to transcription-targeting chemotherapy.
Immunexpress, a molecular diagnostics company focused on improving outcomes for patients with suspected sepsis, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results